Talking Points: N.J. biotech plans to manufacture vaccines in new Mass. plant Boston Globe | August 2, 2021
New Jersey pharma company to purchase Frederick R&D facility Baltimore Business Journal | July 27, 2021
More Than Vaccines: Tonix Programs Address the Spectrum of Covid-19 Problems from Prevention, to Infection to Post-Viral Syndrome Benzinga | July 15, 2021
Dr. Seth Lederman discusses T Cell Immunity and COVID-19 on Technology Networks Technology Networks | June 1, 2021
Dr. Seth Lederman Discusses COVID-19 Vaccine durability and further development on Bloomberg Radio Bloomberg | May 25, 2021
Dr. Seth Lederman interviewed on Nobel Laureate Economist on Vaccine Equity Bloomberg | March 23, 2021
Positive Phase 3 Efficacy Data Bolsters Tonix Pharmaceuticals' Expectations For Phase 3 Confirmatory Trial In Fibromyalgia Benzinga | March 19, 2021
Tonix Pharmaceuticals CEO Believes That Additional COVID-19 Vaccine Research Is Still Needed Benzinga | February 2, 2021
